Acadia Pharmaceuticals (ACAD)'s 30-day implied volatility (IV30) was 52.7% at the close on November 9, 2026, up from 26.8% the day before, against a 52-week range of 23.0% to 114.7%. Its 20-day historical volatility was 33.2%.
Data as of November 9, 2026.